ANTIBIOTIC SUSCEPTIBILITY AND MOLECULAR PROPERTIES OF STRAIN STREPTOCOCCUS PYOGENES FROM PATIENTS WITH SOFT TISSUE INFECTIONS AND ANGINA

Cover Page


Cite item

Full Text

Abstract

Aim. To compare the molecular properties and antibiotic susceptibility of GAS isolates in patients with respiratory and soft tissue infections. Materials and methods. 86 GAS isolates from patients with respiratory infections and 91 isolates with soft tissue infections were studied. The antimicrobial susceptibility profile of six antibiotics (clindamycin, erythromycin, azithromycin, clarithromycin, tetracycline, levofloxacin) was performed by the microdilution method. PCR and sequencing were used in emm-typing and detection SpeA, SpeB and SpeC genes. Results. Emm-types: 49, 66, 88 and 169 were the most prevalent in patients with soft tissue infections, and 1, 3, 12, 28, 75, 89 - in patients with respiratory infections. One strain was new. Isolates were representatives of the three patterns (A-C, D, E). 116 strains of both groups comprised to pattern E. 15 strains (21%) exclusively from soft tissue infections comprised to pattern D. More than half of isolates from patients with soft tissue infections had resistant to tetracycline. Resistance to macrolides was determined in both groups. In each of the studied groups were isolated strains with multidrug resistant. Eryphrogenic toxins gene A and C was more frequently in respiratory isolates. Conclusion. The group of respiratory GAS was less heterogenic in emm-types composition. Pattern D was not contain any pharyngeal GAS strains. Eryphrogenic toxin gene speA was identified twice as likely in respiratory isolates. The use of tetracycline and macrolides would be ineffective in approximately half of the cases among the patients with soft tissue infections.

About the authors

S. I. Briko

Sechenov First Moscow State Medical University

Author for correspondence.
Email: noemail@neicon.ru
Россия

E. V. Glushkova

Sechenov First Moscow State Medical University

Email: noemail@neicon.ru
Россия

D. A. Kleymenov

Sechenov First Moscow State Medical University

Email: noemail@neicon.ru
Россия

N. F. Dmitrieva

Sechenov First Moscow State Medical University

Email: noemail@neicon.ru
Россия

K. V. Lipatov

Sechenov First Moscow State Medical University

Email: noemail@neicon.ru
Россия

A. V. Devyatkin

Infectious Clinical Hospital No. 1

Email: noemail@neicon.ru
Россия

V. E. Malikov

Infectious Clinical Hospital No. 1

Email: noemail@neicon.ru
Россия

References

  1. Брико Н.И., Покровский В.И., Клейменов Д.А. Распространенность и клиникоэпидемиологическая характеристика заболеваний, вызываемых стрептококком группы А в России. Терапевтический архив. 2009, 11: 5-9.
  2. Дмитриева Н.Ф., Трофимов Д.Ю., Ещина А.С., Ряпис Л.А., Скоркина Ю.А., Герасимов А.Н., Журавлев М.В., Брико Н.И. Частота встречаемости генов spe АВС в штаммах Streptococcus puogenes и идентификация возбудителя с помощью ПЦР. Журн микро-биол. 2002, 5: 3-6.
  3. Маниатис Т, Фрич Э., Сэмбрук Д. Методы генетической инженерии. Молекулярное клонирование. М., Мир, 1984.
  4. Покровский В.И., Брико Н.И., Ряпис Л.А. Стрептококки и стрептококкозы. М., ГЭОТАР-*Медиа, 2006.
  5. Ряпис Л.А., Брико Н.И., Ещина А.С., Дмитриева Н.Ф. Стрептококки: общая характеристика и методы лабораторной диагностики. М., Идеал-Пресс, 2009.
  6. Bessen D.E., McShan W.M., Nguyenet S.V. et al. Molecular epidemiology and genomics of group A Streptococcus. Infect. Genet. Evol. 2015, 33: 393-418.
  7. Carapetis J.R., Steer A. C., Mulholland E.K. et al. The current evidence for the burden of group A streptococcal diseases. Lancet Infect. Dis. 2005, 5 (11): 685-694.
  8. Cole J.N., Barnett T.C., Nizet V. et al. Molecular insight into invasive group A streptococcal disease. Nature Rev. Microbiol. 2011, 9: 724-736.
  9. Dale J.B., Penfound T.A., Chiang E.Y. et al. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against nonvaccine serotypes of group A streptococci. Vaccine. 2011, 29:8175-8178.
  10. Fittipaldi N., Olsen R.J., Beres S.B. et al. Genomic analysis of emm59 group A Streptococcus invasive strains, United States. EID J. 2012, 4: 18.
  11. ’Loughlin R.E., Roberson A., Cieslak P.R. et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin. Infect. Dis. 2007, 45: 853-862.
  12. Sanderson-Smith M., De Oliveira D.M., Guglielmini J. et al. A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. J. Infect. Dis. 2014, 210 (8): 1325-1338.
  13. Swedo S.E., Leonard H.L., Garvey M. et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am. J. Psychiatry. 1998, 155: 264-271.
  14. Williamson D.A., Smeesters P.R., Steer A.C. et al. Comparative M-protein analysis of Streptococcus pyogenes from pharyngitis and skin infections in New Zealand: Implications for vaccine development. BMC Infectious Diseases. 2016, 16: 561.
  15. Yaddanapudi K., Homig M., Serge R. et al. Passive transfer of streptococcus induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol. Psychiatry. 2010, 15: 712-726.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Briko S.I., Glushkova E.V., Kleymenov D.A., Dmitrieva N.F., Lipatov K.V., Devyatkin A.V., Malikov V.E.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies